Best Practices in the
Management of Cancer Pain
RELEASE DATE: October 2003
EXPIRATION DATE: October 31, 2004
and undertreatment of acute and chronic cancer pain are common occurrences.
Barriers to appropriate treatment include lack of awareness of the principles
and benefits of cancer pain therapy among patients and their families,
and among many clinicians. Education of patients and their families, and
of healthcare providers, is essential to improve the treatment of cancer
pain. Essential components of improved therapy include quantitative assessment
of pain and eliminating the "fear" of opioid therapy. This review
is designed to help clinicians recognize the need for patient education
and patient participation in selection and administration of analgesic
regimens, and to provide such therapy according to current published guidelines.
This educational activity
is intended for physicians, pharmacists, and nurses involved in the management
of patients with cancer.
the completion of this activity, participants should be able to:
current guidelines for the treatment of patients with cancer pain
specific concerns and recommendations related to the use of opioid analgesics
among cancer patients
- Apply recommendations
for detection and quantitative evaluation of pain in all cancer patients,
with particular attention to minority patients
AND CREDIT DESIGNATION:
This activity has
been planned and implemented in accordance with the Essential Areas and
policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of the Dannemiller Memorial Educational
Foundation and McMahon Publishing Group. The Dannemiller Memorial Educational
Foundation is accredited by the ACCME to provide continuing medical education
The Dannemiller Memorial
Educational Foundation designates this educational activity for a maximum
of 1 category 1 credit toward the AMA Physician's Recognition Award. Each
physician should claim only those credits that he/she actually spent in
Only US licensed
physicians may be awarded AMA PRA category 1 credit by accredited providers.
Certificates of participation may be provided to all other health professionals.
The Dannemiller Memorial
Educational Foundation is an approved provider of the California Board
of Registered Nursing. Provider approved by the California Board of Registered
Nursing, Provider Number 4229, for 1 contact hour.
University is accredited by the American Council on Pharmaceutical Education
as a provider of continuing pharmaceutical education. This is a continuing
education activity of Purdue, an equal access/equal opportunity university.
To receive the 1 contact hour of continuing education credit, pharmacists
should complete the activity requirements and evaluation at the conclusion
of the monograph. Approval is valid from the initial release date of October
23, 2003. The expiration date is October 31, 2004. Program Number 018-999-03-103-H01.
This activity should
take approximately 1 hour to complete. The participant should, in order,
read the objectives, other introductory material, and online monograph,
answer the 10-question multiple-choice online post-test, and complete
the evaluation. The evaluation form provides each participant with the
opportunity to comment on the quality of the instructional process, the
perception of enhanced professional effectiveness, the perception of commercial
bias, and his/her views on future educational needs. To receive credit
for this activity, follow the post-test instructions. There is no fee
associated with this activity. This credit will be valid through October
31, 2004. No credit will be given after this date.
For questions regarding
the content of this activity, contact Dannemiller Memorial Educational
Foundation, accredited provider for this activity, at firstname.lastname@example.org.
For technical assistance, contact email@example.com.
Explorer (v5.5 or greater) or Netscape
(v7.2 or greater)
Windows 98, SE or above; OR Mac 10.2; 800 x 600 minimum monitor resolution
(1024 x 768 recommended)
Betty Ferrell, PhD,
City of Hope Medical Center
Andre Weinberger, MD
It is the policy of the Dannemiller
Memorial Educational Foundation that faculty participating in a continuing
medical education activity disclose to participants any significant financial
interest or other relationship (1) with the manufacturer(s) of any commercial
product(s) and/or provider(s) of commercial services discussed in an educational
presentation, and (2) with any commercial supporters of the activity.
Dr. Ferrell discloses that
she is a member of the speakers bureau for Purdue Pharma, LP, and serves
on the advisory board for Watson Pharmaceuticals, Inc.
This monograph was drafted
by Andre Weinberger, MD, who has no relationships to disclose. The content
of this activity was controlled and approved by the faculty.
To access the
please click on the logo.
sponsored by the Dannemiller Memorial Educational Foundation and
McMahon Publishing Group.
pharmacists by Purdue University.
is supported through an unrestricted educational grant from Purdue Pharma,
Nurses Click Here